ResearcherCold Spring Harbor LaboratoryNo recent work listed
Lindsey A. Baker
Matched on ORCID iD 0000-0002-3098-2231; OpenAlex author ID A5059127216; NIH RePORTER profile ID 8483570. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 44
2015: 1 paper · 2016: 2 papers · 2017: 1 paper, 1 grant · 2018: none · 2019: 4 papers · 2020: 2 papers
Papers 10
- SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. Co-author DOI 10.1084/jem.20192389↗
- Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes. First author DOI 10.1158/2159-8290.cd-20-0133↗
- Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/978-1-4939-8879-2_10↗
- Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens. Co-author DOI 10.1007/978-1-4939-8879-2_9↗
- Organoid models for translational pancreatic cancer research. Co-author DOI 10.1016/j.gde.2019.02.003↗
- Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-1398↗
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Co-author DOI 10.1084/jem.20162024↗
- Modeling pancreatic cancer with organoids. Co-author DOI 10.1016/j.trecan.2016.03.004↗
- Model organoids provide new research opportunities for ductal pancreatic cancer. Co-author DOI 10.1080/23723556.2015.1014757↗
- Organoid models of human and mouse ductal pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.12.021↗
Grants 1
Closest collaborators
The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Arthur Tuveson · 10 shared papers, 2015–2020 · strength 0.97
- Paper Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma. DOI 10.1007/978-1-4939-8879-2_10↗
- Paper Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens. DOI 10.1007/978-1-4939-8879-2_9↗
- Paper Organoid models for translational pancreatic cancer research. DOI 10.1016/j.gde.2019.02.003↗
- Hervé Tiriac · 7 shared papers, 2015–2020 · strength 0.62
- Paper Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens. DOI 10.1007/978-1-4939-8879-2_9↗
- Paper Organoid models for translational pancreatic cancer research. DOI 10.1016/j.gde.2019.02.003↗
- Paper Modeling pancreatic cancer with organoids. DOI 10.1016/j.trecan.2016.03.004↗
- Chang‐Il Hwang · 6 shared papers, 2015–2020 · strength 0.39
- Paper SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. DOI 10.1084/jem.20192389↗
- Paper Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular… DOI 10.1158/2159-8290.cd-20-0133↗
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Youngkyu Park · 5 shared papers, 2015–2020 · strength 0.32
- Paper SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. DOI 10.1084/jem.20192389↗
- Paper Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular… DOI 10.1158/2159-8290.cd-20-0133↗
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Tobiloba E. Oni · 4 shared papers, 2015–2020 · strength 0.24
- Paper SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. DOI 10.1084/jem.20192389↗
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Hans C. Clevers · 4 shared papers, 2015–2017 · strength 0.24
- Paper Modeling pancreatic cancer with organoids. DOI 10.1016/j.trecan.2016.03.004↗
- Paper Model organoids provide new research opportunities for ductal pancreatic cancer. DOI 10.1080/23723556.2015.1014757↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Dannielle D. Engle · 4 shared papers, 2015–2019 · strength 0.22
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Model organoids provide new research opportunities for ductal pancreatic cancer. DOI 10.1080/23723556.2015.1014757↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Giulia Biffi · 3 shared papers, 2015–2020 · strength 0.16
- Paper SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. DOI 10.1084/jem.20192389↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Paper Organoid models of human and mouse ductal pancreatic cancer. DOI 10.1016/j.cell.2014.12.021↗
- Christopher R. Vakoc · 2 shared papers, 2020 · strength 0.16
- Tim D.D. Somerville · 2 shared papers, 2020 · strength 0.16
- Mariano Ponz‐Sarvisé · 3 shared papers, 2015–2019 · strength 0.15
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Paper Organoid models of human and mouse ductal pancreatic cancer. DOI 10.1016/j.cell.2014.12.021↗
- Iok In Christine Chio · 3 shared papers, 2015–2019 · strength 0.15
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Paper Organoid models of human and mouse ductal pancreatic cancer. DOI 10.1016/j.cell.2014.12.021↗
- Vincenzo Corbo · 3 shared papers, 2015–2019 · strength 0.15
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Paper Organoid models of human and mouse ductal pancreatic cancer. DOI 10.1016/j.cell.2014.12.021↗
- Daniel Öhlund · 3 shared papers, 2015–2019 · strength 0.15
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. DOI 10.1084/jem.20162024↗
- Paper Organoid models of human and mouse ductal pancreatic cancer. DOI 10.1016/j.cell.2014.12.021↗
- Hao Yuan · 2 shared papers, 2015–2020 · strength 0.11
- Brinda Alagesan · 2 shared papers, 2015–2020 · strength 0.11
- Ralph H. Hruban · 2 shared papers, 2015–2020 · strength 0.11
- Kenneth H. Yu · 2 shared papers, 2015–2019 · strength 0.10
- Sylvia F. Boj · 2 shared papers, 2015–2016 · strength 0.10
- Scott W. Lowe · 1 shared paper, 2020 · strength 0.08
- Claudia Tonelli · 1 shared paper, 2020 · strength 0.08
- Ela Elyada · 2 shared papers, 2015–2017 · strength 0.08
- Benno Traub · 1 shared paper, 2020 · strength 0.08
- Giuseppina Caligiuri · 1 shared paper, 2020 · strength 0.08
- Koji Miyabayashi · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.